Help Moms With Rheumatoid Arthritis

Volunteer for research to improve the health of moms and babies.

MotherToBaby is currently enrolling pregnant women in an observational study to explore how rheumatoid arthritis (RA) and its treatment affect pregnancy. All studies are conducted through phone interviews–-no changes to your normal routine or travel required. If you’ve taken Actemra® (tocilizumab) or Kevzara® (sarilumab) and are pregnant, you may qualify for this important study.‎ 

“There is a huge need to generate more data for all of the drugs that pregnant women need to take.”

— Christina Chambers, PhD, MPH, MotherToBaby Pregnancy Studies

Make an impact on rheumatoid arthritis research by enrolling into our pregnancy study!

Join our Study

Your information is confidential.

Questions? Call 866.626.6847 | Text 855.999.3525 | Email or Chat at

Disclaimer: MotherToBaby Fact Sheets are meant for general information purposes and should not replace the advice of your health care provider. MotherToBaby is a service of the non-profit Organization of Teratology Information Specialists (OTIS). OTIS/MotherToBaby encourages inclusive and person-centered language. While our name still contains a reference to mothers, we are updating our resources with more inclusive terms. Use of the term mother or maternal refers to a person who is pregnant. Use of the term father or paternal refers to a person who contributes sperm. Copyright by OTIS, August 30, 2018.